These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16682889)

  • 1. The authors reply: academic and industry partnerships.
    Goldstein B; Nadel S; Peters M; Barton R; Machado F; Giroir B
    Pediatr Crit Care Med; 2006 May; 7(3):278-9. PubMed ID: 16682889
    [No Abstract]   [Full Text] [Related]  

  • 2. How to ENHANCE our knowledge of activated protein C during pediatric sepsis trials: pediatric versus adult trials.
    Hazelzet JA
    Pediatr Crit Care Med; 2006 May; 7(3):277-8. PubMed ID: 16682888
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated protein C (Xigris): a drug in trouble.
    Vangerow B; Mignini MA
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261-2. PubMed ID: 17261152
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks and benefits of activated protein C treatment for severe sepsis.
    Warren HS; Suffredini AF; Eichacker PQ; Munford RS
    N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing the use of activated protein C in the treatment of severe sepsis.
    Siegel JP
    N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563
    [No Abstract]   [Full Text] [Related]  

  • 6. Drotrecogin alfa on trial.
    Tillotson GS
    Lancet Infect Dis; 2009 Jan; 9(1):2-3. PubMed ID: 19095188
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we treat severe sepsis with activated protein C?
    Mackillop A
    Hosp Med; 2003 May; 64(5):316. PubMed ID: 12789748
    [No Abstract]   [Full Text] [Related]  

  • 8. Science, medicine and industry: are we getting out of the black hole in sepsis research?
    Suter PM; Takala J
    Intensive Care Med; 2008 Nov; 34(11):1950-4. PubMed ID: 18839139
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant human activated protein C sentenced to the death of a thousand cuts?
    O'Brien JM
    Crit Care Med; 2007 Jun; 35(6):1609-10. PubMed ID: 17522532
    [No Abstract]   [Full Text] [Related]  

  • 10. Drotrecogin alfa: too early to give it early.
    Smith B
    Emerg Med Australas; 2005 Apr; 17(2):179-80. PubMed ID: 15796737
    [No Abstract]   [Full Text] [Related]  

  • 11. Should we be using activated protein C to treat severe sepsis?
    Eve RL; Duffy MR
    Br J Hosp Med (Lond); 2009 Aug; 70(8):484. PubMed ID: 19684544
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioethics, the Surviving Sepsis Campaign, and the industry.
    Wiedermann CJ
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):442-4. PubMed ID: 16091869
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioethics, the Surviving Sepsis Campaign and the industry.
    Bion J; Vincent JL; Angood P
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):63. PubMed ID: 16489529
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Röggla G; Moser B
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):65. PubMed ID: 16612881
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Ricevuti G; Gasparetto C
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):64-5. PubMed ID: 16612880
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Mackenzie AF
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):64. PubMed ID: 16612879
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
    Malliani A
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):63-4. PubMed ID: 16612878
    [No Abstract]   [Full Text] [Related]  

  • 18. Xigris: reducing mortality in adult patients with severe sepsis.
    Larson AM
    Urol Nurs; 2002 Jun; 22(3):200-1. PubMed ID: 12087796
    [No Abstract]   [Full Text] [Related]  

  • 19. Once is not enough: clinical trials in sepsis.
    Sweeney DA; Danner RL; Eichacker PQ; Natanson C
    Intensive Care Med; 2008 Nov; 34(11):1955-60. PubMed ID: 18839140
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescribing indications based on successful clinical trials in sepsis: a difficult exercise.
    Carlet J
    Crit Care Med; 2006 Feb; 34(2):525-9. PubMed ID: 16424736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.